Larotrectinib Capsules and Mycophenolic Acid Delayed-Release Tablets
Determining the interaction of Larotrectinib Capsules and Mycophenolic Acid Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Mycophenolic Acid Tablets
- Larotrectinib Capsules-Mycostatin (Nystatin Oral Suspension)
- Larotrectinib Capsules-Mycostatin (Nystatin Tablets and Capsules)
- Larotrectinib Capsules-Mycostatin Suspension
- Larotrectinib Capsules-Mydayis
- Larotrectinib Capsules-Mydayis ER Capsules
- Mycophenolic Acid Delayed-Release Tablets-Larotrectinib Oral Solution
- Mycophenolic Acid Delayed-Release Tablets-Larotrectinib Sulfate
- Mycophenolic Acid Delayed-Release Tablets-Lartruvo
- Mycophenolic Acid Delayed-Release Tablets-Larynex
- Mycophenolic Acid Delayed-Release Tablets-Laryng-O-Jet
- Mycophenolic Acid Delayed-Release Tablets-Laryngesic